Management of Upper Tract Urothelial Carcinoma
- 25 February 2022
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 24 (5) , 611-619
Abstract
Purpose of Review We review the epidemiology, risk factors, diagnosis, and treatment of upper tract urothelial carcinoma (UTUC), with a distinction between the different risk groups. Recent Findings Endoscopic treatment with laser ablation of tumors has an evolving role in treating low-grade UTUC including select large and multifocal tumors, along with complementary topical chemotherapeutic treatment that can reach difficult intrarenal locations. Template lymphadenectomy is recommended in patients undergoing nephroureterectomy. A recent randomized control trial showed benefit of adjuvant chemotherapy after radical nephroureterectomy for locally advanced disease. Advances in immunologic therapy have shown promise in treating metastatic UTUC, and immunologic-based therapies have been incorporated into treatment regimens. Summary Notable progress has been made in both the surgical and medical treatment arms for UTUC, thus extending the reach of nephron-sparing therapy for those with localized disease and increasing overall survival for those with locally advanced disease.Keywords
This publication has 57 references indexed in Scilit:
- Ureteroscopic management of upper tract urothelial carcinoma ( UTUC ) in patients with L ynch S yndrome (hereditary nonpolyposis colorectal cancer syndrome)BJU International, 2013
- Extravasation of Intravesical Chemotherapy for Non-Muscle-Invasive Bladder CancerUrologia Internationalis, 2012
- Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?European Urology, 2011
- Impact of Diagnostic Ureteroscopy on Intravesical Recurrence and Survival in Patients With Urothelial Carcinoma of the Upper Urinary TractJournal of Urology, 2010
- Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriersJournal of Medical Genetics, 2010
- Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinomaCancer, 2010
- Carcinoma of the upper urinary tractCancer, 2009
- IMPACT OF DIAGNOSTIC URETEROSCOPY ON LONG-TERM SURVIVAL IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMAJournal of Urology, 1999
- FACTORS AFFECTING THE OCCURRENCE OF UROTHELIAL TUMORS IN DYE WORKERS EXPOSED TO AROMATIC MINESInternational Journal of Urology, 1995
- Does Flexible Ureteropyeloscopy Promote Local Recurrence of Transitional Cell Carcinoma?Journal of Endourology, 1994